| Descriptor English: | Lamivudine | ||||||
| Descriptor Spanish: |
Lamivudine
| ||||||
| Descriptor Portuguese: | Lamivudina | ||||||
| Descriptor French: | Lamivudine | ||||||
| Entry term(s): |
2',3' Dideoxy 3' thiacytidine 2',3'-Dideoxy-3'-thiacytidine 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- 3TC Lamivudine BCH 189 BCH-189 BCH189 Epivir GR-109714X GR109714X Lamivudine, (+)-cis- Lamivudine, (+-)-trans- Lamivudine, (2S-cis)-Isomer |
||||||
| Tree number(s): |
D03.383.742.680.245.500.950.500 D13.570.230.329.950.500 D13.570.230.500.925.500 D13.570.685.245.500.950.500 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019259 | ||||||
| Scope note: | A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Reverse Transcriptase Inhibitors Anti-HIV Agents |
||||||
| Registry Number: | 2T8Q726O95 | ||||||
| CAS Type 1 Name: | 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- | ||||||
| Previous Indexing: |
Cytosine/analogs & derivatives (1991-1992) Zalcitabine/analogs & derivatives (1993-1996) |
||||||
| Public MeSH Note: | 97; LAMIVUDINE was indexed under ZALCITABINE/analogs & derivatives 1993-96 and CYTOSINE/analogs & derivatives 1991-92 |
||||||
| Online Note: | use LAMIVUDINE (NM) to search LAMIVUDINE 1991-96 |
||||||
| History Note: | 97; was LAMIVUDINE (NM) 1991-96 |
||||||
| DeCS ID: | 33070 | ||||||
| Unique ID: | D019259 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1997/01/01 | ||||||
| Date of Entry: | 1996/06/10 | ||||||
| Revision Date: | 2021/10/18 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Lamivudine
- Preferred
Epivir
- Narrower
Lamivudine, (2S-cis)-Isomer
- Narrower
BCH-189
- Related but not broader or narrower
GR-109714X
- Narrower
Lamivudine, (+)-cis-
- Narrower
Lamivudine, (+-)-trans-
- Narrower
| Concept UI |
M0028682 |
| Scope note | A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease. |
| Preferred term | Lamivudine |
| Entry term(s) |
2',3' Dideoxy 3' thiacytidine 2',3'-Dideoxy-3'-thiacytidine 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)- 3TC Lamivudine |
| Concept UI |
M0028684 |
| Preferred term | Epivir |
| Concept UI |
M0329185 |
| Preferred term | Lamivudine, (2S-cis)-Isomer |
| Concept UI |
M0028683 |
| Preferred term | BCH-189 |
| Entry term(s) |
BCH 189 BCH189 |
| Concept UI |
M0372433 |
| Preferred term | GR-109714X |
| Entry term(s) |
GR109714X |
| Concept UI |
M000751242 |
| Preferred term | Lamivudine, (+)-cis- |
| Concept UI |
M000751245 |
| Preferred term | Lamivudine, (+-)-trans- |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey